89 related articles for article (PubMed ID: 20518349)
1. [Design and activity analysis of chimeric epidermal growth factor fusion vaccine E5T-mSEA].
Yin Q; Jia H; Zhang Y; Liu C; Ma Q; Zhang B; Zhong H; Xu Q
Sheng Wu Gong Cheng Xue Bao; 2010 Mar; 26(3):357-62. PubMed ID: 20518349
[TBL] [Abstract][Full Text] [Related]
2. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
3. Preparation and In Vitro Evaluation of Antitumor Activity of TGFαL3-SEB as a Ligand-Targeted Superantigen.
Yousefi F; Mousavi SF; Siadat SD; Aslani MM; Amani J; Rad HS; Fooladi AA
Technol Cancer Res Treat; 2016 Apr; 15(2):215-26. PubMed ID: 25759426
[TBL] [Abstract][Full Text] [Related]
4. Construction, Expression, and Characterization of rSEA-EGF and In Vitro Evaluation of its Antitumor Activity Against Nasopharyngeal Cancer.
Liu X; Zeng L; Zhao Z; Xie Y; Wang S; Zhang J; He Y; Zou Z; Zhang J; Tao A
Technol Cancer Res Treat; 2018 Jan; 17():1533033818762910. PubMed ID: 29551087
[TBL] [Abstract][Full Text] [Related]
5. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
[TBL] [Abstract][Full Text] [Related]
6. Anti-EGFR activation, anti-proliferative and pro-apoptotic effects of polyclonal antibodies induced by EGFR-based cancer vaccine.
Ramírez BS; Alpízar YA; Fernández DR; Hidalgo GG; Capote AR; Rodríguez RP; Fernández LE
Vaccine; 2008 Sep; 26(38):4918-26. PubMed ID: 18672015
[TBL] [Abstract][Full Text] [Related]
7. Effects of epidermal growth factor (EGF), transforming growth factor-alpha (TGFalpha), and 2,3,7,8-tetrachlorodibenzo-p-dioxin on fusion of embryonic palates in serum-free organ culture using wild-type, EGF knockout, and TGFalpha knockout mouse strains.
Abbott BD; Buckalew AR; Leffler KE
Birth Defects Res A Clin Mol Teratol; 2005 Jun; 73(6):447-54. PubMed ID: 15880701
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
9. [Expression of epidermal growth factor-adenovirus E4orf4 fusion protein in tumor cells and its cytotoxicity].
Bu PL; Wang DM; Chen H; Huang BR
Ai Zheng; 2005 Jan; 24(1):33-9. PubMed ID: 15642197
[TBL] [Abstract][Full Text] [Related]
10. [Immunotherapeutic effect of recombinant EGFR phage vaccine on tumors].
Liu D; Tang L; Zhou CC; Tan LS
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):728-32. PubMed ID: 17366781
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of the growth-inhibitory effect of the RNase-EGF fused protein against EGFR-overexpressing cells.
Hoshimoto S; Ueda M; Jinno H; Kitajima M; Futami J; Seno M
Anticancer Res; 2006; 26(2A):857-63. PubMed ID: 16619480
[TBL] [Abstract][Full Text] [Related]
12. [Expression of xenogentic epidermal growth factor receptor ectodomain and its antitumor effect].
Li YH; Tang L; Liu Q; Chen DK; Tan LS
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Nov; 24(11):1051-4. PubMed ID: 18992189
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression.
Wang Y; Li J; Ying Wang C; Yan Kwok AH; Leung FC
Endocrinology; 2007 Jul; 148(7):3426-40. PubMed ID: 17395697
[TBL] [Abstract][Full Text] [Related]
14. The EGF/TGFalpha response element within the TGFalpha promoter consists of a multi-complex regulatory element.
Awwad R; Humphrey LE; Periyasamy B; Scovell W; Li W; Coleman K; Lynch M; Carboni J; Brattain MG; Howell GM
Oncogene; 1999 Oct; 18(43):5923-35. PubMed ID: 10557079
[TBL] [Abstract][Full Text] [Related]
15. Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.
Goldstein J; Graziano RF; Sundarapandiyan K; Somasundaram C; Deo YM
J Immunol; 1997 Jan; 158(2):872-9. PubMed ID: 8993006
[TBL] [Abstract][Full Text] [Related]
16. Generation and activity of a humanized monoclonal antibody that selectively neutralizes the epidermal growth factor receptor ligands transforming growth factor-α and epiregulin.
Beidler CB; Petrovan RJ; Conner EM; Boyles JS; Yang DD; Harlan SM; Chu S; Ellis B; Datta-Mannan A; Johnson RL; Stauber A; Witcher DR; Breyer MD; Heuer JG
J Pharmacol Exp Ther; 2014 May; 349(2):330-43. PubMed ID: 24518034
[TBL] [Abstract][Full Text] [Related]
17. Expression of TGFalpha autocrine activity in human colon carcinoma CBS cells is autoregulated and independent of exogenous epidermal growth factor.
Jiang D; Liang J; Humphrey LE; Yang H; Brattain MG
J Cell Physiol; 1998 May; 175(2):174-83. PubMed ID: 9525476
[TBL] [Abstract][Full Text] [Related]
18. Fusion of the genes encoding Escherichia coli heat-stable enterotoxin b (STb) and the maltose-binding protein to obtain mature STb enterotoxin.
Bossé M; Handl CE; Lortié LA; Harel J; Dubreuil JD
J Gen Microbiol; 1993 Mar; 139(3):631-8. PubMed ID: 8473869
[TBL] [Abstract][Full Text] [Related]
19. The enlargement of the hormone immune deprivation concept to the blocking of TGFalpha-autocrine loop: EGFR signaling inhibition.
Mulet A; Garrido G; Alvarez A; Menéndez T; Böhmer FD; Pérez R; Fernández LE
Cancer Immunol Immunother; 2006 Jun; 55(6):628-38. PubMed ID: 16328386
[TBL] [Abstract][Full Text] [Related]
20. A bispecific enediyne-energized fusion protein containing ligand-based and antibody-based oligopeptides against epidermal growth factor receptor and human epidermal growth factor receptor 2 shows potent antitumor activity.
Guo XF; Zhu XF; Shang Y; Zhang SH; Zhen YS
Clin Cancer Res; 2010 Apr; 16(7):2085-94. PubMed ID: 20332319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
